USA – Sequel, a San Francisco, CA-based startup engineering health and wellness experiences for women starting with a leakage-preventing tampon, raised $5m in seed funding.
MaC VC, Pear Accelerator, Long Journey Ventures, Ulu Ventures, Graph Ventures and other strategic angels, including Cyan Banister and Nurx CEO Varsha Rao, contributed to this round. The company intends to use the funds to bring its first novel product to market. Led by Greta Meyer, CEO, and Amanda Calabrese, COO, both Stanford product design engineering students and elite athletes, Sequel is engineering health and wellness experiences for women starting with a leakage-preventing tampon that relies on a proprietary, fluid-mechanically-efficient design. With two granted patents and three patents pending, the company’s proprietary spiral design absorbs fluid evenly and won’t leak before it’s full. The team spent a year in research and development to invent their new-and-improved tampon. They tested the product on the bench and with early beta testers, and built out an all-new manufacturing method. They are preparing to submit for FDA clearance in the new year and take the product to market in 2022. Sequel is also working with star gymnast, artist and activist, Katelyn Ohashi as a creative advisor.23/12/2021
